Professur für Arzneimitteltherapiesicherheit und Klinische Pharmakologie

L-Arginine and Cardioactive Arginine Derivatives as Substrates and Inhibitors of Human and Mouse NaCT/Nact (2022) Surrer D, Fromm M, Maas R, König J Journal article Identification of diagnosis-related contraindications based on the medication plan alone (2022) Andrikyan W, Then M, Gassmann KG, Tuemena T, Dürr P, Fromm M, Maas R Conference contribution A LC-HRMS method for drug exposure measurement of 57 oral anticancer drugs in human plasma (2022) Kehl N, Dürr P, Schlichtig K, Maas R, Fromm M, Geßner A, Taudte V Conference contribution Prescription of QT interval prolonging drugs in Germany and discrepancies between their Summary of Product Characteristics and the international CredibleMeds((R)) database (2022) Then M, Andrikyan W, Maas R, Fromm M Conference contribution Effects of treatment with SGLT-2 inhibitors on arginine-related cardiovascular and renal biomarkers (2022) Geßner A, Gemeinhardt A, Bosch A, Kannenkeril D, Staerk C, Mayr A, Fromm M, et al. Journal article Use of medication data alone to identify diagnoses and related contraindications: Application of algorithms to close a common documentation gap (2022) Andrikyan W, Then M, Gassmann KG, Tuemena T, Dürr P, Fromm M, Maas R Journal article Screening of commonly prescribed drugs for effects on the CAT1-mediated transport of l-arginine and arginine derivatives (2022) Banjarnahor S, König J, Maas R Journal article An easily expandable multi-drug LC-MS assay for the simultaneous quantification of 57 oral antitumor drugs in human plasma (2021) Kehl N, Schlichtig K, Dürr P, Bellut L, Dörje F, Fietkau R, Pavel ME, et al. Journal article Associations of circulating dimethylarginines with the metabolic syndrome in the Framingham Offspring study (2021) Yola IM, Moser C, Duncan MS, Schwedhelm E, Atzler D, Maas R, Hannemann J, et al. Journal article The Randomized AMBORA Trial: Impact of Pharmacological/Pharmaceutical Care on Medication Safety and Patient-Reported Outcomes During Treatment With New Oral Anticancer Agents (2021) Dürr P, Schlichtig K, Kelz C, Deutsch B, Maas R, Eckart MJ, Wilke J, et al. Journal article